Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 0 | -0.62 | -1.11 | -1.03 | -5.02 | -6.34 |
PEG Ratio | 0 | 0.02 | 0.02 | 0 | 0.08 | 0.06 |
PS Ratio | n/a | n/a | 6.2K | 174.64 | 26.71 | 27.17 |
PB Ratio | 0 | 1.20 | 0.93 | 7.69 | 7.93 | 37.22 |
P/FCF Ratio | 0 | -0.76 | -0.87 | -1.28 | -5.14 | -7.41 |
P/OCF Ratio | 0 | -0.76 | -0.87 | -1.28 | -5.16 | -7.64 |
OCF/S Ratio | n/a | n/a | -709.2K | -13.64K | -517.63 | -355.58 |
Debt / Equity Ratio | n/a | n/a | 0.09 | 0.14 | 0.06 | 0.23 |
Quick Ratio | 1.40 | 6.05 | 5.55 | 1.33 | 2.60 | 1.66 |
Current Ratio | 1.40 | 6.05 | 5.55 | 1.37 | 2.71 | 1.74 |
Asset Turnover | n/a | n/a | 0 | 0.01 | 0.19 | 0.60 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -9.56 |
Return on Equity | -159.81% | -192.87% | -83.85% | -746.66% | -157.92% | -586.86% |
Return on Assets | -59.10% | -161% | -68.87% | -250.79% | -101.50% | -256.31% |
Return on Invested Capital | -155.31% | -186.76% | -100.97% | -660.32% | -172.04% | -163.68% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | -226.67% | 86.96% | 90.24% |
Net Profit Margin | n/a | n/a | -556.9K% | -16.96K% | -531.72% | -428.44% |
Pretax Profit Margin | n/a | n/a | -556.9K% | -17.01K% | -575.10% | -153.10% |
Operating Profit Margin | n/a | n/a | -727.7K% | -17.06K% | -612.98% | -151.94% |
FCF Margin | n/a | n/a | -709.4K% | -13.64K% | -519.13% | -366.74% |
EBITDA Margin | n/a | n/a | -716.5K% | -16.73K% | -598.49% | -145.91% |
Add to Watchlist
Select watchlists to add or remove TTNP